HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Danielle MacNeil Selected Research

Neoplasms (Cancer)

12/2023Tumor volumes in T3 supraglottic cancers treated with radiotherapy in the modern era: A study of the Canadian Head & Neck Collaborative Research Initiative.
11/2023Oncologic Significance of Therapeutic Delays in Patients With Oral Cavity Cancer.
1/2023Association of Primary Tumor Volume With Survival in Patients With T3 Glottic Cancer Treated With Radiotherapy: A Study of the Canadian Head & Neck Collaborative Research Initiative.
1/2022The Impact of Surgical Resectability on Outcomes for Patients Undergoing Primary Radiation Treatment for Human Papillomavirus-Related Oropharyngeal Cancer.
1/2022Tumor molecular differences associated with outcome disparities of Black patients with head and neck cancer.
10/20213p Arm Loss and Survival in Head and Neck Cancer: An Analysis of TCGA Dataset.
1/2021All HPV-negative head and neck cancers are not the same: Analysis of the TCGA dataset reveals that anatomical sites have distinct mutation, transcriptome, hypoxia, and tumor microenvironment profiles.
1/2021Detection of Circulating Tumor DNA in Patients with Thyroid Nodules.
12/2020Analysis of the TCGA Dataset Reveals that Subsites of Laryngeal Squamous Cell Carcinoma are Molecularly Distinct.
10/2020TAM family receptors in conjunction with MAPK signalling are involved in acquired resistance to PI3Kα inhibition in head and neck squamous cell carcinoma.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Danielle MacNeil Research Topics

Disease

17Neoplasms (Cancer)
12/2023 - 09/2017
10Squamous Cell Carcinoma of Head and Neck
10/2021 - 09/2014
3Head and Neck Neoplasms (Head and Neck Cancer)
10/2021 - 09/2017
2Oropharyngeal Neoplasms
12/2022 - 01/2022
2Anaplastic Thyroid Carcinoma
01/2020 - 01/2018
2Squamous Cell Neoplasms (Squamous Cell Cancer)
09/2017 - 09/2014
1Neoplasm Metastasis (Metastasis)
12/2023
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2022
1Thyroid Nodule (Nodule, Thyroid)
01/2021
1Hypoxia (Hypoxemia)
12/2020
1Carcinogenesis
10/2019
1Wounds and Injuries (Trauma)
01/2018
1Myxoma (Myxomas)
09/2014
1Vaccinia
09/2014
1Uterine Cervical Neoplasms (Cancer of the Cervix)
09/2014

Drug/Important Bio-Agent (IBA)

5Proteins (Proteins, Gene)FDA Link
10/2021 - 09/2014
5NucleotidesIBA
10/2021 - 01/2019
3Biomarkers (Surrogate Marker)IBA
12/2022 - 09/2014
3Messenger RNA (mRNA)IBA
01/2021 - 01/2020
2MicroRNAs (MicroRNA)IBA
01/2022 - 10/2021
2DNA (Deoxyribonucleic Acid)IBA
01/2021 - 01/2019
2Mechanistic Target of Rapamycin Complex 2IBA
01/2020 - 10/2019
1ProteomeIBA
10/2021
1RNA (Ribonucleic Acid)IBA
10/2021
1human MIRN421 microRNAIBA
10/2021
1Circulating Tumor DNAIBA
01/2021
1AlpelisibIBA
10/2020
1Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
10/2020
1Syk KinaseIBA
01/2020
1alvocidib (flavopiridol)IBA
01/2020
1maleic acid (maleate)IBA
01/2020
1ChemokinesIBA
01/2020
1Cisplatin (Platino)FDA LinkGeneric
10/2019
1Phosphatidylinositols (Phosphatidylinositol)IBA
10/2019
1lestaurtinibIBA
01/2018
1Albendazole (Albenza)FDA Link
09/2017
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
09/2014
1ErbB Receptors (EGF Receptor)IBA
09/2014

Therapy/Procedure

6Therapeutics
11/2023 - 01/2018
4Radiotherapy
12/2023 - 01/2022
3Drug Therapy (Chemotherapy)
01/2023 - 01/2020
2Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
12/2023 - 01/2023
1Laryngectomy
12/2023
1Adjuvant Radiotherapy
12/2023
1Aftercare (After-Treatment)
12/2023
1Treatment Delay
11/2023
1Neoadjuvant Therapy
10/2019